Skip to main content
. Author manuscript; available in PMC: 2014 Jan 29.
Published in final edited form as: Leuk Lymphoma. 2008 Jun;49(6):1074–1080. doi: 10.1080/10428190801993470

Table III.

Patient characteristics of responders by transplant status.

Characteristic Responders who received a transplant directly after RDHAP (n=15) Responders who did not receive a transplant (n=31)
Age, years
 Mean±S.D. 60.5±9.8 65.4±9.0
 Median (Min, Max) 61 (45, 75) 64 (48, 83)
Bulky Disease 5 (33%) 9 (29%)
Number of prior chemotherapies
 Mean 2.1 2.4
 Median (Min, Max) 2 (1, 5) 2 (1, 7)
IPI Score
 0 1 (7%) 2 (6%)
 1 4 (27%) 10 (32%)
 2 6 (40%) 7 (23%)
 3 4 (27%) 10 (32%)
 4 0 (0%) 2 (6%)
Disease type
 Small lymphocytic 0 (0%) 3 (10%)
 Mantle Cell 2 (13%) 2 (6%)
 Follicular 1 (7%) 9 (29%)
 Diffuse large cell 9 (60%) 14 (45%)
 Nodal Marginal Zone 0 (0%) 1 (3%)
 High Grade, Burkitt-like 0 (0%) 1 (3%)
 Unclassifiable 3 (20%) 1 (3%)